Ling Zhi (Reishi Mushroom or ganoderma)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Ling Zhi (Reishi)?

  Roughly 3–15 g in decoction, or 1.5–3 g as powder — Chen & Chen give this as the standard range for the dried fruiting body. Modern commercial reishi products (spore powder, extracts, capsules) are typically dosed per the manufacturer’s standardization rather than the classical decoction range, and are not directly interchangeable with raw-herb dosing.

  Source: Sacred Lotus sources & references (Chen & Chen). Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Ling Zhi (Reishi)?

  Ling Zhi is considered gentle and well tolerated at traditional doses — the materia medica record notes no significant classical contraindications. The main modern-era cautions relate to long-term, high-dose use of concentrated commercial extracts/powders rather than the traditional decoction.

  • Digestive/mild effects — dry mouth, throat irritation, nausea, or loose stools have been reported with high-dose or prolonged extract use.
  • Use in pregnancy, and before surgery or with bleeding disorders — warrants practitioner guidance given the research-context cautions below (anticoagulant/antiplatelet interaction and rare hepatotoxicity reports with concentrated products).

  Source: Sacred Lotus sources & references; cross-referenced against multiple online sources. Reference note, not medical advice.

Chinese Herb Toxicity & Overdose

• Low at traditional decoction doses, but rare serious liver injury has been reported with concentrated lingzhi powder/extract products. Published case reports describe hepatotoxicity and one fatal fulminant hepatitis associated with lingzhi (Ganoderma lucidum) formulations/mushroom powder, and a more recent case report reviewed acute liver injury in the setting of concurrent alcohol use. These are rare, product-specific reports (often implicating concentrated extracts, not the classical crude herb) rather than a common effect, but they support caution with high-dose or long-term supplement use and disclosure of use to a physician.

  Source: Yuen MF et al., J Hepatol 2004, PMID 15464254 (hepatotoxicity case report); Wanmuang H et al., J Med Assoc Thai 2007, PMID 17621752 (fatal fulminant hepatitis case); Guedikian R et al., Cureus 2023, PMID 37885515 (acute liver injury case report and literature review). Reference note, not a safety guarantee.

Herb-Drug Interactions

• Practitioner caution is warranted with anticoagulant/antiplatelet medications (e.g. warfarin, aspirin, clopidogrel) because of Ling Zhi’s traditional and research-context association with effects on blood/circulation and its immune-modulating activity. A clinical herb–drug interaction review for cancer care specifically flags reishi mushroom for interaction awareness alongside other commonly used botanicals in oncology settings. Given reishi’s documented immunostimulatory activity, some caution is also reasonable for patients on immunosuppressant therapy (e.g. post-transplant) or those on antihypertensive medication, though robust clinical interaction data are limited. (Precautionary, flagged for practitioner confirmation — not a demonstrated interaction in controlled trials.)

  Source: Yeung KS, Gubili J, Mao JJ, “Herb-Drug Interactions in Cancer Care,” Oncology (Williston Park) 2018, PMID 30334243.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Ling Zhi / reishi (Ganoderma lucidum)?

  Yes — a large preclinical and immunology-adjunct literature exists, but a Cochrane systematic review found insufficient evidence to support Ganoderma lucidum as primary cancer therapy. Most human data are small trials of polysaccharide extracts used alongside conventional treatment, not the whole dried herb.

  • Cochrane systematic review (cancer) — the 2016 update of a Cochrane review of Ganoderma lucidum for cancer treatment concluded the evidence was not sufficient to justify its use as a standalone cancer therapy, though it noted potential as an adjunct alongside conventional treatment for possibly enhancing immune response, with no significant hematological or hepatic toxicity reported across the pooled studies and only minor adverse events (e.g. nausea, insomnia) in some trials.
  • Immune function in advanced cancer (small clinical trials) — randomized studies of a standardized Ganoderma lucidum polysaccharide extract (Ganopoly) reported improved measures of immune function in patients with advanced-stage cancer, and a separate trial reported similar immune-marker changes with a water-soluble polysaccharide extract in advanced lung cancer patients; both are small, extract-specific trials, not evidence of a cure.
  • Cancer-related fatigue (pilot RCT) — a pilot randomized trial of Ganoderma lucidum spore powder in breast cancer patients on endocrine therapy reported improved fatigue and physical well-being scores versus control; a single small pilot study.

  Overall, human clinical evidence remains limited in size and rigor; the strongest current statement is that reishi is well tolerated in trials and shows immune-modulating activity worth further study, not a demonstrated treatment for any disease.

  Sources: Jin X et al., Cochrane Database Syst Rev 2016, PMID 27045603 (systematic review); Gao Y et al., Immunol Invest 2003, PMID 12916709; Gao Y et al., J Med Food 2005, PMID 16117607; Zhao H et al., Evid Based Complement Alternat Med 2012, PMID 22203880. Research context, not a therapeutic claim.

Chinese Herb Notes

• Is Ling Zhi the same as “reishi” supplements, and how does it differ from other calming/tonic herbs?

  Yes — Ling Zhi is the Chinese materia medica name for the same fungus marketed in the West as “reishi,” principally the fruiting body of Ganoderma lucidum (a closely related dark-capped species, Ganoderma sinense, is also official in the Chinese Pharmacopoeia and traded under the same name). Both red (chi) and other color forms are described in classical sources, though red Ling Zhi is most commonly seen commercially.

  • Vs. Suan Zao Ren / Bai Zi Ren — these seed-based Heart-calming herbs are used more specifically for Blood/Yin-deficient insomnia; Ling Zhi is milder and doubles as a Qi/Blood tonic and Lung herb, making it suitable for broader deficiency-with-fatigue presentations rather than insomnia alone.
  • Raw vs. processed / extract forms — the whole fruiting body (decocted or powdered) is the classical form; modern research mostly uses standardized polysaccharide or spore-powder extracts, which concentrate specific fractions rather than the whole herb.

  Source: Sacred Lotus sources & references (Chen & Chen); cross-referenced against multiple online sources.